Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Harriet Kluger"'
Autor:
Harriet Kluger, Nikhil Joshi, Marcus Bosenberg, Lilach Aizenbud, Noah Hornick, Esen Sefik, Goran Micevic, Andrew Daniels, Karine Flem-Karlsen, Koonam Park, Ronan Talty, Meaghan McGeary, Haris Mirza, Holly N Blackburn, Julie F Cheung, Akiko Iwasaki, Richard Flavell
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/18f6bffe16e3475ea18d151820853ec1
Autor:
Harriet Kluger, David Rimm, Kelly Olino, David A Schoenfeld, David Su, Wael Ibrahim, Raymond Baumann, Anjela Galan, Jim Clune
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/97bf601627ea4743b3e1f1047cf8c11e
Autor:
Mario Sznol, Harriet Kluger, Michael Hurwitz, Adebowale Adeniran, Peter Humphrey, David Braun, Lena Wirth, Soki Kashima, Hanna Soulati, Katrine Madsen, Katherine Sadak, Patrick Kenney
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ae26b4bac3ae4c5685120cdd4801bbc5
Autor:
James Larkin, Harriet Kluger, Omid Hamid, Jeffrey Weber, Amod A Sarnaik, Brian Gastman, Jeffrey Chou, John M Kirkwood, Eric Whitman, Martin Wermke, Evidio Domingo-Musibay, Theresa Medina, Sajeve Thomas, Wen Shi, Xiao Wu, Jason A Chesney, Giri Sulur, Friedrich Graf Finckenstein
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/dd15fbf338ed45b1a76ce053944ef9df
Autor:
Lin Zhang, Harriet Kluger, Lucia Jilaveanu, Gabriela Athziri Sanchez-Zuno, Jasmine Caulfield, Lin Leng, Richard Bucala, Thuy Tran
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c7d736a6a30847aa898a5b991e8dd542
Autor:
Mario Sznol, Harriet Kluger, Igor Puzanov, Gerald S Falchook, Ryan Sullivan, Matthew H Taylor, Justin C Moser, Aaron M Ring, Virginia E Paton, David Chonzi, Brage Garofalo, Mark Sonnemann, Hirdesh Uppal, Jeremy Barton, Beatrice Y McQueen
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/c9d6a589d3ec4c688bdb430c28cf8a3d
Autor:
Lin Zhang, Harriet Kluger, Lucia Jilaveanu, David A Schoenfeld, Dijana Djureinovic, Jacqueline Mann, John Huck, Aaron M Ring
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss Suppl 1 (2023)
Externí odkaz:
https://doaj.org/article/ec0db54c3f69417c888449ad5f6c9355
Autor:
Stephen S Rich, Harriet Kluger, Lucia Jilaveanu, Eric Meffre, Adebowale Adeniran, Jasmine I Caulfield, Lilach Aizenbud, Ana Luisa Perdigoto, Dominika A Michalek, Yariv Aizenbud, Kevan C Herold, Matthew R Austin
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Background Immune checkpoint inhibitors (ICIs) have dramatically improved survival in patients with cancer but are often accompanied by severe immune-related adverse events (irAEs), which can sometimes be irreversible. Insulin-dependent diabetes is a
Externí odkaz:
https://doaj.org/article/11462355bf844340b590147aa6990955
Autor:
Harriet Kluger, Omid Hamid, Roberta Zappasodi, Michael Hurwitz, Hussein Tawbi, Elad Sharon, Theresa LaVallee, Rebecca A Moss, Justin F Gainor, J Carl Barrett, Ryan J Sullivan
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Immunotherapy is the standard of care for several cancers and the field continues to advance at a rapid pace, with novel combinations leading to indications in an increasing number of disease settings. Durable responses and long-term survival with im
Externí odkaz:
https://doaj.org/article/6400d9b9bb3148028d7abaef119802cc
Autor:
James L Gulley, Harriet Kluger, Hussein Tawbi, Jeffrey Sosman, Paolo A Ascierto, Michael B Atkins, Nikhil I Khushalani, Douglas B Johnson, Timonthy A Yap, Ryan J Sullivan, David Feltquate
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 11, Iss 3 (2023)
Immunotherapy offers deep and durable disease control to some patients, but many tumors do not respond to treatment with single-agent immune checkpoint inhibitors (ICIs). One strategy to enhance responses to immunotherapy is via combinations with sig
Externí odkaz:
https://doaj.org/article/2fe026f8decc4254bd877fb5ec451060